---
figid: PMC9108399__ijmsv19p0659g002
figtitle: Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family
  Receptor Alpha (GFRA) in Cancers
organisms:
- NA
pmcid: PMC9108399
filename: ijmsv19p0659g002.jpg
figlink: /pmc/articles/PMC9108399/figure/F2/
number: F2
caption: 'GFRα and treatment resistance. Chemoresistance: Cisplatin stimulates overexpression
  of GFRα1 via NFκB phosphorylation and decreases cisplatin-induced apoptosis, accompanied
  by increased autophagy, and significantly promotes cell proliferation through the
  SRC-AMPK signaling axis. Endocrine resistance: GFLs/GFRα/RET and ER signaling participate
  in intricate crosstalk via the PI3K/mTOR and RAS/MEK/ERK pathways in breast cancer.
  Endocrine therapy promotes the expression of GFLs, resulting in a vicious loop of
  RET signaling. Hypoxia resistance: Hypoxia directly activates ARTN transcription
  via HIF-1α, and the ARTN-dependent AKT pathway is then activated to trigger expansion
  of the CSC population. The solid arrows indicate the known and direct interactions
  between signaling molecules; the broken arrows indicate interactions requiring further
  investigation. The red arrows indicate the main GFRα signaling pathway.'
papertitle: The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family
  Receptor Alpha (GFRα) in Cancers.
reftext: Qingshang Li, et al. Int J Med Sci. 2022;19(4):659-668.
year: '2022'
doi: 10.7150/ijms.64133
journal_title: International Journal of Medical Sciences
journal_nlm_ta: Int J Med Sci
publisher_name: Ivyspring International Publisher
keywords: GFRα1 | GDNF | cancer | neural invasion | treatment resistance
automl_pathway: 0.9624186
figid_alias: PMC9108399__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9108399__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9108399__ijmsv19p0659g002.html
  '@type': Dataset
  description: 'GFRα and treatment resistance. Chemoresistance: Cisplatin stimulates
    overexpression of GFRα1 via NFκB phosphorylation and decreases cisplatin-induced
    apoptosis, accompanied by increased autophagy, and significantly promotes cell
    proliferation through the SRC-AMPK signaling axis. Endocrine resistance: GFLs/GFRα/RET
    and ER signaling participate in intricate crosstalk via the PI3K/mTOR and RAS/MEK/ERK
    pathways in breast cancer. Endocrine therapy promotes the expression of GFLs,
    resulting in a vicious loop of RET signaling. Hypoxia resistance: Hypoxia directly
    activates ARTN transcription via HIF-1α, and the ARTN-dependent AKT pathway is
    then activated to trigger expansion of the CSC population. The solid arrows indicate
    the known and direct interactions between signaling molecules; the broken arrows
    indicate interactions requiring further investigation. The red arrows indicate
    the main GFRα signaling pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - GFRA1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SRC
  - FGR
  - FYN
  - YES1
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SNAI1
  - KLF4
  - ARTN
  - HIF1A
  - SETD2
  - ARNT
---
